Year-End Report

TEVA PHARMACEUTICALS USA, INC. for TEVA PHARMACEUTICALS USA INC

Firm
Client
Income
—
Expenses
$1,160,000

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

President Bush FY 2008 Budget Request - $15.7 million dollars Generic Drug User Fees. Matters relating to FDA Office of Generic Drugs funding.

LobbyistCovered position, as disclosed
DEBRA BARRETT N/A
DAVID SANDERS N/A

Contacted: Food & Drug Administration (FDA); UNDETERMINED; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); SENATE

Trade (domestic/foreign) TRD

Matters relating to Israeli data exclusivity. Matters relating to pharmaceutical provisions in free trade agreements.

LobbyistCovered position, as disclosed
DEBRA BARRETT N/A
DAVID SANDERS N/A

Contacted: Food & Drug Administration (FDA); UNDETERMINED; U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Pharmacy PHA

S. 25 - Citizen Petition Fairness and Accuracy Act of 2007 S. 623 - Access to Life-Saving Medicine Act S. 438 - Fair Prescription Drug Competition Act H.R. 806 - Fair Prescription Drug Competition Act

LobbyistCovered position, as disclosed
DEBRA BARRETT N/A
DAVID SANDERS N/A

Contacted: Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); UNDETERMINED; Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC)

Bills named: S. 25 (110th), H.R. 806 (110th), S. 623 (110th), S. 438 (110th)

Copyright/Patent/Trademark CPT

H.R. 1432 - Preserve Access to Affordable Generics Act S. 316 - Preserve Access to Affordable Generics Act H.R. 1908 - Patent Reform Act of 2007 S. 1145 - Patent Reform Act of 2007

LobbyistCovered position, as disclosed
DEBRA BARRETT N/A
DAVID SANDERS N/A

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); UNDETERMINED; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); SENATE

Bills named: H.R. 1432 (110th), S. 316 (110th), S. 1145 (110th), H.R. 1908 (110th)

Medicare/Medicaid MMM

H.R. 976 - Children's Health Insurance Program Reauthorization Act of 2007 S. 1893 - Children's Health Insurance Program Reauthorization Act of 2007 H.R. 3162 - Children's Health and Medicare Protection Act of 2007 S. 1951 - The Fair Medicaid Drug Payment Act of 2007

LobbyistCovered position, as disclosed
DEBRA BARRETT N/A
DAVID SANDERS N/A

Contacted: UNDETERMINED; SENATE; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1893 (110th), H.R. 3162 (110th), H.R. 976 (110th), S. 1951 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.